+1-888-308-5802     
News Contact Us

Telix signs PI Medical as distribution partner in Netherlands

Author : Sunil Hebbalkar | Published Date : 2019-07-03 

PI Medical to receive exclusive rights to distribution of TLX591- CDx in Netherlands

Australia headquartered - Telix Pharmaceuticals, a clinical stage biopharma company has reportedly signed Netherlands- based PI Medical Diagnostic Equipment for the distribution of TLX591-CDx cold kit in Netherlands.

For the record, Telix Pharmaceuticals focuses on the development of therapeutic and diagnostic development of products based on molecularly targeted radiation (MTR). Based in Melbourne, the company has international presence in Japan, Europe and United States. Currently, the company is developing a portfolio of clinical stage cancer treatment products that meet the required need for brain, renal and prostate cancer treatment.

Ludovic Wouters, VP Corporate Development at Telix Pharmaceuticals was reportedly quoted stating that for several months the company has been informally researching and working with the PI Medical and aim at establishing a concrete commercial relationship focusing on the availability of PSMA imaging cold kit. With the help of PI Medical’s nuclear medicine expertise and their recognition in the market, Telix Pharmaceuticals can easily establish itself in the Dutch market, he further stated.

PI Medical Diagnostic Equipment was founded in January 1995 and is a commercially strong Netherlands based company produces nuclear medicines and focuses on radiology and radiotherapy market. The company has developed equipments for sentinel gland procedures. The products range from nuclear medicines, radiotherapy, radiology to operating rooms.

The Managing Director of PI Medical reportedly claimed that the collaborating companies complement each other, concerning PI’s expertise in nuclear medicines and Telix’s products. The theranostic product portfolio of the company includes gallium-based products and the use of Lutetium- 177, a therapeutic isotope, he added.

The collaboration is a multi-product agreement whereby PI Medical will receive the exclusive rights to the distribution of TLX591 – CDx, a prostate cancer imaging in Netherlands and non- exclusive distribution rights in the Flemish region of Belgium.

Reportedly, the financial details related to the deal have not been disclosed so far.

Source Credits: https://www.globenewswire.com/news-release/2019/07/02/1877033/0/en/Telix-Pharmaceuticals-and-PI-Medical-Sign-Distribution-Agreement-for-the-Netherlands.html

About Author

Sunil Hebbalkar

Sunil Hebbalkar

Sunil Hebbalkar currently works as a content writer for fractovia.org and other portals. A post graduate in mechanical design engineering, he nurtures a passion for writing articles related to myriad industry verticals such as the technology, automotive, and healthcare sectors. When free, Sunil pursues his interest in cycling, reading, and sketching. He can be contacted at- [email protected] | https://twitter.com/HSuniel

Related News

Del Monte to shut its Sleepy Eye plant & lay-off all employees on site

Published Date: 2019-08-23         Author: Sunil Hebbalkar

The Sleepy Eye plant closure would be waving hundreds of seasonal jobs and 69 full time jobs.   This closure is just a part of the greater vision of Del Monte’s parent company, Del Monte Pacific ­Limited based in Singapore, to close or sell most of its U.S. assets. Del Mon... Read More

Del Monte to shut its Sleepy Eye plant & lay-off all employees on site

Published Date: 2019-08-22         Author: Sunil Hebbalkar

The Sleepy Eye plant closure would be waving hundreds of seasonal jobs and 69 full time jobs.   This closure is just a part of the greater vision of Del Monte’s parent company, Del Monte Pacific ­Limited based in Singapore, to close or sell most of its U.S. assets. Del Mon... Read More

Hyundai Motor halts production subject to tough market conditions

Published Date: 2019-08-19         Author: Sunil Hebbalkar

The carmaker has declared no production days for some departments due to slowdown in the automobile sector. Engine Shop-1 and Engine Shop-2 are expected to face the no production days for ten and nice shifts respectively. The nation's second largest car-maker Hyundai Motors, India has ... Read More

© 2019 Fractovia. All Rights Reserved